Viridian Therapeutics, Inc. (VRDN)
19.15
-0.41
(-2.10%)
USD |
NASDAQ |
Apr 01, 16:00
18.60
-0.55
(-2.87%)
Pre-Market: 09:17
Viridian Therapeutics Research and Development Expense (TTM) : 338.47M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 11.80M |
| Plus Therapeutics, Inc. | 8.379M |
| Nutriband, Inc. | 2.193M |
| Immunovant, Inc. | 408.02M |
| Definium Therapeutics, Inc. | 117.66M |